54 related articles for article (PubMed ID: 24370587)
1. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
2. SirT7-mediated transcription of fascin in hyperglycemic glomerular endothelial cells contributes to EndMT in diabetic nephropathy.
Wu M; Hao Y; Wu X; Zhu M; Chen X; Qi J; Yu Z; Xu H
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):586-596. PubMed ID: 38449390
[TBL] [Abstract][Full Text] [Related]
3. Protective mechanism of apigenin in diabetic nephropathy is related to its regulation of miR-423-5P-USF2 axis.
Hou Y; Zhang Y; Lin S; Yu Y; Yang L; Li L; Wang W
Am J Transl Res; 2021; 13(4):2006-2020. PubMed ID: 34017372
[TBL] [Abstract][Full Text] [Related]
4. A Nucleoside/Nucleobase-Rich Extract from
Dong Z; Sun Y; Wei G; Li S; Zhao Z
Molecules; 2019 Nov; 24(22):. PubMed ID: 31739543
[No Abstract] [Full Text] [Related]
5. Microbial imidazole propionate affects glomerular filtration rate in patients with diabetic nephropathy through association with HSP90α.
Lv D; Zheng W; Zhang Z; Lin Z; Wu K; Liu H; Liao X; Sun Y
Biochim Biophys Acta Mol Cell Res; 2024 Apr; 1871(4):119703. PubMed ID: 38453032
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a SUCNR1 antagonist for potential treatment of diabetic nephropathy: In silico and in vitro studies.
Zhang X; Lyu D; Li S; Xiao H; Qiu Y; Xu K; Chen N; Deng L; Huang H; Wu R
Int J Biol Macromol; 2024 May; 268(Pt 2):131898. PubMed ID: 38677680
[TBL] [Abstract][Full Text] [Related]
7. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway.
Hagiwara S; McClelland A; Kantharidis P
J Diabetes Res; 2013; 2013():173783. PubMed ID: 24575418
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29b inhibits diabetic nephropathy in db/db mice.
Chen HY; Zhong X; Huang XR; Meng XM; You Y; Chung AC; Lan HY
Mol Ther; 2014 Apr; 22(4):842-53. PubMed ID: 24445937
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Jiang P; Yao C; Guo DA
Acta Pharm Sin B; 2024 Jan; 14(1):38-66. PubMed ID: 38239236
[TBL] [Abstract][Full Text] [Related]
11. Tongxinluo enhances the effect of atorvastatin on the treatment of atherosclerosis with chronic obstructive pulmonary disease by maintaining the pulmonary microvascular barrier.
Kuang X; Wang Y; Liu S; Chang L; Yin Y; Li Z; Liu Y; Li W; Hou Y; Wang H; Liang J; Jia Z
Food Sci Nutr; 2023 Jan; 11(1):390-407. PubMed ID: 36655081
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Renal Protection and Antioxidative Stress Effects of Panax notoginseng Saponins in Diabetic Nephropathy Mice.
Mi W; Yu M; Yin S; Ji Y; Shi T; Li N
J Immunol Res; 2022; 2022():3610935. PubMed ID: 36249425
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy.
Liu S; Wu W; Liao J; Tang F; Gao G; Peng J; Fu X; Zhan Y; Chen Z; Xu W; Zhao S
Front Endocrinol (Lausanne); 2022; 13():895010. PubMed ID: 35865316
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy and Mechanism of Chinese Herbal Medicine on Diabetic Kidney Disease.
Lu Z; Zhong Y; Liu W; Xiang L; Deng Y
J Diabetes Res; 2019; 2019():2697672. PubMed ID: 31534972
[TBL] [Abstract][Full Text] [Related]
15. Tangshen Formula Treatment for Diabetic Kidney Disease by Inhibiting Racgap1-stata5-Mediated Cell Proliferation and Restoring miR-669j-Arntl-Related Circadian Rhythm.
Wang X; Zhao H; Wu X; Xi G; Zhou S
Med Sci Monit; 2018 Nov; 24():7914-7928. PubMed ID: 30394366
[TBL] [Abstract][Full Text] [Related]
16. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.
Xue M; Cheng Y; Han F; Chang Y; Yang Y; Li X; Chen L; Lu Y; Sun B; Chen L
Int J Biol Sci; 2018; 14(11):1545-1557. PubMed ID: 30263007
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.
Wang X; Gao Y; Tian N; Zou D; Shi Y; Zhang N
Drug Des Devel Ther; 2018; 12():2431-2442. PubMed ID: 30122901
[TBL] [Abstract][Full Text] [Related]
18. Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway.
Qi K; Li X; Geng Y; Cui H; Jin C; Wang P; Li Y; Yang Y
PLoS One; 2018; 13(6):e0198403. PubMed ID: 29912977
[TBL] [Abstract][Full Text] [Related]
19. Metformin ameliorates skeletal muscle insulin resistance by inhibiting miR-21 expression in a high-fat dietary rat model.
Wang J; Gao Y; Duan L; Wei S; Liu J; Tian L; Quan J; Zhang Q; Liu J; Yang J
Oncotarget; 2017 Nov; 8(58):98029-98039. PubMed ID: 29228671
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1.
Chen GH; Xu CS; Zhang J; Li Q; Cui HH; Li XD; Chang LP; Tang RJ; Xu JY; Tian XQ; Huang PS; Xu J; Jin C; Yang YJ
Front Pharmacol; 2017; 8():775. PubMed ID: 29163161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
